CERTAIN INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. OMISSIONS ARE MARKED *** AMENDMENT NO. 2 TO AMENDED AND RESTATED DEVELOPMENT AND COMMERCIALIZATION...Development and Commercialization Agreement • February 23rd, 2024 • Insulet Corp • Surgical & medical instruments & apparatus
AMENDMENT NO. 1 TO PURCHASE AGREEMENTPurchase Agreement • February 23rd, 2024 • Insulet Corp • Surgical & medical instruments & apparatus
This Amendment No. 1 to Purchase Agreement (this "Amendment No. 1") is dated as of the 30th day of November, 2019 (the "Amendment Effective Date"), by and between lnsulet Corporation, a Delaware corporation, having a place of business at 100 Nagog Park, Acton, Massachusetts 01720 on behalf of itself and its worldwide affiliates ("Purchaser"), and NXP USA, Inc., with an office located at 6501 William Cannon Drive West, Austin, Texas 78735 on behalf of itself and its affiliates ("Supplier").
CERTAIN INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. OMISSIONS ARE MARKED *** AMENDMENT NO. 1 to the AMENDED AND RESTATED DEVELOPMENT AND...Development and Commercialization Agreement • February 23rd, 2024 • Insulet Corp • Surgical & medical instruments & apparatus
This Amendment No. 1 to the Amended and Restated Development and Commercialization Agreement (“Amendment”) is dated as of the 5th day of January, 2022 (“Effective Date”), by and between Insulet Corporation (“Insulet”) and Abbott Diabetes Care Inc. (“ADC”).
AMENDED AND RESTATED DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • February 23rd, 2024 • Insulet Corp • Surgical & medical instruments & apparatus • Delaware
This AMENDED AND RESTATED DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (the “Agreement”) is entered into as of September 13, 2021 (the “Amended Effective Date”) by and between Abbott Diabetes Care Inc., a Delaware corporation having its principal place of business at 1420 Harbor Bay Parkway, Alameda, CA 94502 (“ADC”), and Insulet Corporation, a Delaware corporation having its principal place of business at 100 Nagog Park, Acton, MA 01720 (“Insulet”), each of which is referred to as a “Party” and collectively referred to as the “Parties.”
PURCHASE AGREEMENTPurchase Agreement • February 23rd, 2024 • Insulet Corp • Surgical & medical instruments & apparatus • New York
THIS PURCHASE AGREEMENT (this “Agreement”), entered into as of October 12, 2017 (“Effective Date”) by and between Insulet Corporation, a Delaware corporation, having a place of business at 600 Technology Park Drive, Suite 200, Billerica, MA 01821 on behalf of itself and its Affiliates (“Purchaser”), and NXP USA, Inc., with an office located at 6501 William Cannon Drive West, Austin, Texas 78735 (“Supplier”) on behalf of itself and its Affiliates.
